摘要 |
The present invention relates to Glutathione S-transferase (GST)/Reduced Glutathione (GSH) as a means for the in-vivo release of a drug that has been conjugated to specific electrophilic moieties via a sulfonamide bond. The drug may be an anticancer agent (or one with other therapeutic properties) carrying a free -NH- which has been derivatized by the attachment of an electrophile containing a moiety, such as p-CN- or p-NO2-pyridinylsulfonyl groups, or p-NO2- or 2,4 dinitrophenylsulfonyl groups, or suitable derivatives thereof, to make a prodrug. Optionally, the sulfonamide moiety may have attached to it a targeting molecule. The present invention also provides Glutathione S-transferase (GST)/Reduced Glutathione (GSH) as a means for the release of a protected amino derivative that has been conjugated to specific electrophilic moieties via a sulfonamide bond. The precursor is a synthetic intermediate carrying a free -NH- which has been derivatized by the attachment of an electrophile via a sulfonamide bond. |
申请人 |
PHARMACIA & UPJOHN COMPANY;ZHAO, ZHIYANG;TOMASSELLI, ALFREDO, G.;KOEPLINGER, KENNETH, A.;PETERSON, TILLIE;SUARATO, ANTONINO |
发明人 |
ZHAO, ZHIYANG;TOMASSELLI, ALFREDO, G.;KOEPLINGER, KENNETH, A.;PETERSON, TILLIE;SUARATO, ANTONINO |